B. Warren
Pope
(Warren)

Defending Newell Brands and certain of its directors and officers in securities class actions arising out of stock price drops following disappointing financial results.

Defending Equifax, Inc. and certain of its directors and officers in securities class action and derivative litigation following September 2017 data security incident.

Defending Capitala Finance Corp. and certain of its directors and officers in securities class action litigation arising out of disappointing quarterly results.

Representing Triangle Capital Corporation in securities class action arising out of disappointing quarterly results.  Defended Triangle and its Board in M&A litigation challenging its $1 billion transactions with Benefit Street Partners and Barings.  Defeated attempt to stop transactions. 

Defended Aaron's, Inc. and certain of its directors and officers in securities class action litigation arising out of a quarterly earnings miss and revised financial guidance.  Won motion to dismiss.

Defended Special Committee of Books-A-Million Board in an action challenging a going-private transaction in Delaware Chancery Court; obtained dismissal of all claims, affirmed on appeal by Delaware Supreme Court.

Defending FleetCor Technologies, Inc. and certain of its officers in securities class action and derivative litigation arising out of short-seller reports criticizing Company's business practices.

Defended Laboratory Corporation of America Holdings in various 10b-5 securities class actions in the Middle District of North Carolina, obtaining dismissal of all claims.

Defended Commscope and its officers in 10b-5 litigation in the Western District of North Carolina, obtaining dismissal of all claims.

Defended Galectin Therapeutics, Inc. and its directors and officers in securities class action and derivative action, obtaining dismissal of all claims at district court level.  Successfully argued appeal to the Eleventh Circuit, which affirmed dismissal.

Represented TransEnterix in 10b-5 securities class action in the Eastern District of North Carolina and certain of its officers and directors in related derivative litigation.  Won dismissal of class action which led to voluntary dismissal of derivative action.

Defended World Acceptance Corporation in 10b-5 securities class action and shareholder derivative litigation in the District of South Carolina, obtaining favorable resolution of all claims.

Defended the Carmike Cinemas Board of Directors in the Middle District of Georgia against securities and fiduciary duty claims arising out of its proposed merger with AMC; obtained denial of TRO motion to enjoin shareholder vote.  Case later dismissed.

Represented Eclipsys Corporation and its directors in shareholder class actions challenging the $1.3 billion merger of Eclipsys and Allscripts in the Georgia state courts; obtained a full dismissal with prejudice.

Defended Caremark Rx, Inc. and its directors and officers in class action and shareholder derivative litigation in both Delaware and Tennessee regarding the Company's $26 billion merger with CVS Corporation.